NCT00837265 2024-04-03NEUGR-002Teva Branded Pharmaceutical Products R&D, Inc.Phase 2/3 Completed334 enrolled 16 charts
NCT01126190 2023-03-28NEUGR-003Teva Branded Pharmaceutical Products R&D, Inc.Phase 3 Completed381 enrolled 13 charts
NCT01940601 2015-01-14Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid TumorsTeva Branded Pharmaceutical Products R&D, Inc.Phase 2 Withdrawn